TODD STRATEGY GROUP

Lobbying for BRIDGEBIO PHARMA · Biopharmaceutical manufacturer.

Filing 2nd Quarter - Termination

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $20,000.00 income · posted Oct 11, 2025

Lobbying activity 1

Pharmacy

PBM Policy Reform. Prior authorization. Utilization management.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem